1-4 of 4
Morton Coleman
Close
Sort by
Journal Articles

Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study

Clinical Trials & Observations
Stephen Opat, Alessandra Tedeschi, Bei Hu, Kim M. Linton, Pamela McKay, Sophie Leitch, Morton Coleman, Pier Luigi Zinzani, Jie Jin, Mingyuan Sun, Magdalena Sobieraj-Teague, Peter Browett, Xiaoyan Ke, Catherine Thieblemont, Kirit Ardeshna, Fontanet Bijou, Patricia Walker, Eliza A. Hawkes, Shir-Jing Ho, Keshu Zhou, Zhiyu Liang, Jianfeng Xu, Chris Tankersley, Richard Delarue, Melannie Co, Judith Trotman
Journal: Blood Advances
Blood Adv (2023) 7 (22): 6801–6811.
https://doi.org/10.1182/bloodadvances.2023010668
Published: 2023
Includes: Supplemental data
Journal Articles

Involved-site radiotherapy for Helicobacter pylori –independent gastric MALT lymphoma: 26 years of experience with 178 patients

Clinical Trials & Observations
Joachim Yahalom, Amy J. Xu, Ariela Noy, Stephanie Lobaugh, Monica Chelius, Karen Chau, Carol Portlock, Carla Hajj, Brandon S. Imber, David J. Straus, Craig H. Moskowitz, Morton Coleman, Andrew D. Zelenetz, Zhigang Zhang, Ahmet Dogan
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1830–1836.
https://doi.org/10.1182/bloodadvances.2020003992
Published: 2021
Journal Articles

Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis

Clinical Trials & Observations
Ariela Noy, Sven de Vos, Morton Coleman, Peter Martin, Christopher R. Flowers, Catherine Thieblemont, Franck Morschhauser, Graham P. Collins, Shuo Ma, Shachar Peles, Stephen D. Smith, Jacqueline C. Barrientos, Elizabeth Chong, Shiquan Wu, Leo W.-K. Cheung, Kevin Kwei, Bernhard Hauns, Israel Arango-Hisijara, Robert Chen
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5773–5784.
https://doi.org/10.1182/bloodadvances.2020003121
Published: 2020
Includes: Supplemental data
Journal Articles

Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma

Clinical Trials & Observations
Tomer M. Mark, Peter A. Forsberg, Adriana C. Rossi, Roger N. Pearse, Karen A. Pekle, Arthur Perry, Angelique Boyer, Linda Tegnestam, David Jayabalan, Morton Coleman, Ruben Niesvizky
Journal: Blood Advances
Blood Adv (2019) 3 (4): 603–611.
https://doi.org/10.1182/bloodadvances.2018028027
Published: 2019
Includes: Supplemental data